BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 1615932)

  • 1. Neuroendocrine phenotype in lung cancers. Comparison of immunohistochemistry with biochemical determination of enolase isoenzymes.
    Brambilla E; Veale D; Moro D; Morel F; Dubois F; Brambilla C
    Am J Clin Pathol; 1992 Jul; 98(1):88-97. PubMed ID: 1615932
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Isoenzyme pattern of enolase in the diagnosis of neuroendocrine bronchopulmonary tumors.
    Batandier C; Brambilla E; Jacrot M; Morel F; Beriel H; Paramelle B; Brambilla C
    Cancer; 1987 Aug; 60(4):838-43. PubMed ID: 3036337
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Isoenzyme pattern of enolase in human lung tumor xenografts in nude mice.
    Batandier C; Jacrot M; Brambilla E; Beriel H; Brambilla C; Paramelle B
    Anticancer Res; 1987; 7(6):1193-6. PubMed ID: 2831792
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunoreactive neuron-specific enolase, bombesin, and chromogranin as markers for neuroendocrine lung tumors.
    Said JW; Vimadalal S; Nash G; Shintaku IP; Heusser RC; Sassoon AF; Lloyd RV
    Hum Pathol; 1985 Mar; 16(3):236-40. PubMed ID: 3972403
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neuron-specific enolase. Assessment by ELISA in patients with small cell carcinoma of the lung.
    Anastasiades KD; Mullins RE; Conn RB
    Am J Clin Pathol; 1987 Feb; 87(2):245-9. PubMed ID: 3028123
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Monoclonal antibodies to neuron-specific enolase in phenotyping lung cancer].
    Frank GA; Kazesalu IaS; Piĭrsoo AO; Litvinova LV; Vial'tsev NV
    Arkh Patol; 1992; 54(3):12-5. PubMed ID: 1444841
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Enolase isoenzymes in human cerebral metastasis.
    van den Doel EM; Roholl PJ; Rijksen G; van Veelen CW; Staal GE
    Tumour Biol; 1989; 10(3):164-72. PubMed ID: 2762740
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Neuron-specific enolase as a new tumor marker].
    Ariyoshi Y; Kato K; Ishiguro Y; Ota K; Sato T; Suchi T
    Gan To Kagaku Ryoho; 1983 Aug; 10(8):1744-53. PubMed ID: 6349546
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A monoclonal antibody against neuron-specific enolase. Immunohistochemical comparison with a polyclonal antiserum.
    Thomas P; Battifora H; Manderino GL; Patrick J
    Am J Clin Pathol; 1987 Aug; 88(2):146-52. PubMed ID: 3618548
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Enolase isoenzymes as tumour markers.
    Gerbitz KD; Summer J; Schumacher I; Arnold H; Kraft A; Mross K
    J Clin Chem Clin Biochem; 1986 Dec; 24(12):1009-16. PubMed ID: 3029273
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation and clinical value of neuroendocrine differentiation in human prostatic tumors.
    Cussenot O; Villette JM; Cochand-Priollet B; Berthon P
    Prostate Suppl; 1998; 8():43-51. PubMed ID: 9690663
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunohistochemical study of small cell lung carcinoma; with special reference to the neuroendocrine markers aromatic L-amino acid decarboxylase and gastrin-releasing peptide.
    Nakajima T; Shimosato Y; Morinaga S; Terasaki T; Tsumuraya M; Yamaguchi K; Ichinose H; Nagatsu T; Kato K; Nakazato Y
    Jpn J Clin Oncol; 1986 Sep; 16(3):223-33. PubMed ID: 2430122
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Enolase isoenzymes in benign and malignant melanocytic lesions.
    Royds JA; Parsons MA; Rennie IG; Timperley WR; Taylor CB
    Diagn Histopathol; 1982; 5(3):175-81. PubMed ID: 6183083
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antibodies to neuron-specific enolase for the delineation of the entire diffuse neuroendocrine system in health and disease.
    Carlei F; Polak JM
    Semin Diagn Pathol; 1984 Feb; 1(1):59-70. PubMed ID: 6400630
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression and interconversion of neuron-specific enolase in patient sera and extracts from small-cell lung cancer cells.
    Paus E; Myklebust AT
    Tumour Biol; 1996; 17(5):271-80. PubMed ID: 8792853
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of gamma-enolase as a tumor marker for lung cancer.
    Fujita K; Haimoto H; Imaizumi M; Abe T; Kato K
    Cancer; 1987 Aug; 60(3):362-9. PubMed ID: 3036329
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunohistochemistry of neurone specific enolase with gamma subunit specific anti-peptide monoclonal antibodies.
    Murray GI; Duncan ME; Melvin WT; Fothergill JE
    J Clin Pathol; 1993 Nov; 46(11):993-6. PubMed ID: 8254105
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The prognostic significance of neuroendocrine markers and carcinoembryonic antigen in patients with resected stage I and II non-small cell lung cancer.
    Graziano SL; Tatum AH; Newman NB; Oler A; Kohman LJ; Veit LJ; Gamble GP; Coleman MJ; Barmada S; O'Lear S
    Cancer Res; 1994 Jun; 54(11):2908-13. PubMed ID: 8187076
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neuroendocrine differentiation in non-neuroendocrine thyroid carcinoma.
    Kargi A; Yörükoglu ; Aktaş S; Cakalagaoglu ; Ermete M
    Thyroid; 1996 Jun; 6(3):207-10. PubMed ID: 8837328
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phosphoglycerate mutase, 2,3-bisphosphoglycerate phosphatase and enolase activity and isoenzymes in lung, colon and liver carcinomas.
    Durany N; Joseph J; Campo E; Molina R; Carreras J
    Br J Cancer; 1997; 75(7):969-77. PubMed ID: 9083331
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.